Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 8 records, 1 pages
Search For: Ischemic Stroke Therapeutics
Global Ischemic Stroke Therapeutics Supply, Demand and Key Producers, 2024-2030
30 Jan 2024
Medical Care
The global Ischemic Stroke Therapeutics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Ischemic Stroke Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
30 Jan 2024
Medical Care
According to our (Global Info Research) latest study, the global Ischemic Stroke Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Acute Ischemic Stroke Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
02 Jan 2024
Pharma & Healthcare
Acute Ischemic Stroke Therapeutics
According to our (Global Info Research) latest study, the global Acute Ischemic Stroke Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Acute Ischemic Stroke Therapeutics Drugs Supply, Demand and Key Producers, 2024-2030
04 Mar 2024
Medical Care
Acute Ischemic Stroke Therapeutics Drugs
The global Acute Ischemic Stroke Therapeutics Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Acute Ischemic Stroke Therapeutics Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
17 Jan 2024
Medical Care
Acute Ischemic Stroke Therapeutics Drugs
According to our (Global Info Research) latest study, the global Acute Ischemic Stroke Therapeutics Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Global Ischemic Stroke Therapeutics Supply, Demand and Key Producers, 2023-2029
26 Feb 2023
Medical Care
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
USD4480.00
Add To Cart
Global Ischemic Stroke Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
02 Jan 2023
Medical Care
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
USD3480.00
Add To Cart
Global Acute Ischemic Stroke Therapeutics Supply, Demand and Key Producers, 2023-2029
20 Jan 2023
Pharma & Healthcare
Acute Ischemic Stroke Therapeutics
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
USD4480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Ischemic Stroke Therapeutics
Total: 8 records, 1 pages
The global Ischemic Stroke Therapeutics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Ischemic Stroke Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
According to our (Global Info Research) latest study, the global Acute Ischemic Stroke Therapeutics market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
The global Acute Ischemic Stroke Therapeutics Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Acute Ischemic Stroke Therapeutics Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
USD3480.00
Add To Cart
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
USD4480.00
Add To Cart
Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis.
USD3480.00
Add To Cart
AIS is a chronic condition characterized by the sudden loss of blood supply to a part of the brain, thus causing subsequent loss of neurological function. AIS is caused by thrombotic or embolic obstruction of the cerebral artery and is more common than hemorrhagic stroke. The global AIS therapeutics market is expected to register a low single digit market growth during the forecast period. The marginal growth rate is attributed to the lack of approved drugs in this area, the presence of alternative therapies, extensive use of generics, and unmet needs for anticoagulant reversal agents.
USD4480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>